返回列表Patent

TRPV1靶向药物组合物专利在日本和中国提交申请

2022-10-18

The 专利申请s for the 制药 composition for treating TRPV1 activity-mediated diseases have been completed in 日本 and 中国.

Title of Invention

制药 composition for treating TRPV1 activity-mediated diseases

日本 Application Number

(Not yet assigned)

中国 Application Number 2020800866718

Filing Date

(International Filing Date)

2020. 12. 22.

Applicant

RudaCure Co., Ltd.

Inventors

Yongho Kim, Seunghoon Kim, Hawon Jeon, Yuseung Ha

Priority

韩国 专利申请 10-2020-0007433, filed January 20, 2020

Request for Examination

2022. 9. 16.

National Phase Entry Date

2022. 7. 19.

International Application Number

PCT/KR2020/018895

International Publication Number

WO 2021/149925 A1

The requests for examination were filed simultaneously on September 16th, and we will announce again upon registration.

返回列表